Ladenburg Thalmann Downgrades Zosano Pharma (ZSAN) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts ZSAN Hot Sheet
Price: $0.56 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Ladenburg Thalmann downgraded Zosano Pharma (NASDAQ: ZSAN) from Buy to Neutral.
For an analyst ratings summary and ratings history on Zosano Pharma click here. For more ratings news on Zosano Pharma click here.
Shares of Zosano Pharma closed at $1.39 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Downgrades Alignment Healthcare Inc (ALHC) to Neutral
- BofA Securities Downgrades Smithfield Foods (SFD) to Neutral
- Northland sees AI bubble parallels with dotcom era, cuts two stocks
Create E-mail Alert Related Categories
DowngradesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
